Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL28163026 | 1.00 | — | — | |
| Glycine SCHEMBL27902232 | 0.96 | — | — | |
| Glycine SCHEMBL8585762 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL5569329 | 0.96 | — | — | |
| Glycine SCHEMBL21879657 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL6853447 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL6239942 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL20295 | 0.96 | — | — | |
| Glycine SCHEMBL27902160 | 0.92 | — | — | |
| Glycine SCHEMBL27533089 | 0.92 | GLRA1 (0.77) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606903-A1 | PROCESS FOR PURIFYING (METH)ACRYLIC ACID INCLUDING A DIVIDING-WALL DISTILLATION COLUMN | Arkema France (FR) | 2020-02-12 | — | — | EP | claimed |
| EP-3606903-A1 | PROCESS FOR PURIFYING (METH)ACRYLIC ACID INCLUDING A DIVIDING-WALL DISTILLATION COLUMN | Arkema France (FR) | 2020-02-12 | — | — | EP | disclosed |
| US-20050287689-A1 | Method for manufacturing carbon fibers, method for manufacturing electron-emitting device using the same, method for manufacturing electronic device, method for manufacturing image display device, and information display reproduction apparatus using the same | CANON KABUSHIKI KAISHA (JP) | 2005-12-29 | — | — | US | disclosed |
| EP-0606317-B1 | SAPONIN-ANTIGEN CONJUGATES AND THE USE THEREOF | ANTIGENICS INC (US) | 2002-05-22 | — | — | EP | disclosed |
| US-5583112-A | ENHANCING IMMUNE RESPONSES IN ANIMALS | CAMBRIDGE BIOTECH CORPORATION (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0606317-A4 | SAPONIN-ANTIGEN CONJUGATES AND THE USE THEREOF. | CAMBRIDGE BIOTECH CORP (US) | 1995-12-20 | — | — | EP | disclosed |
| EP-0606317-A1 | SAPONIN-ANTIGEN CONJUGATES AND THE USE THEREOF | CAMBRIDGE BIOTECH CORPORATION (US) | 1994-07-20 | — | — | EP | disclosed |
| WO-1993005789-A1 | SAPONIN-ANTIGEN CONJUGATES AND THE USE THEREOF | CAMBRIDGE BIOTECH CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0038784-A2 | 3,8-Dialkylxanthines, processes for their preparation and compositions containing them | Aktiebolaget DRACO (SE) | 1981-10-28 | — | — | EP | disclosed |
| EP-0010531-A1 | 3-Alkylxanthines, processes for their preparation and compositions for use in the treatment of chronic obstructive airway disease and cardiac disease | Aktiebolaget DRACO (SE) | 1980-04-30 | — | — | EP | disclosed |